Similar articles

• [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].

  Malpas J, Mathé G, Hayat M. Malpas J, et al. Bull Cancer. 1974 Jul-Sep;61(3):411-8. Bull Cancer. 1974. PMID: 4533741 Clinical Trial. French. No abstract available.
• A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.

  [No authors listed] [No authors listed] Eur J Cancer (1965). 1974 Jul;10(7):413-8. doi: 10.1016/0014-2964(74)90023-1. Eur J Cancer (1965). 1974. PMID: 4532961 Clinical Trial. No abstract available.
• A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.

  [No authors listed] [No authors listed] Biomedicine. 1973 May;18(3):192-8. Biomedicine. 1973. PMID: 4517790 Clinical Trial. No abstract available.
• The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review.

  Kane D, Keating S, McCann S, Mulcahy F. Kane D, et al. Int J STD AIDS. 1997 Apr;8(4):272-4. doi: 10.1258/0956462971919903. Int J STD AIDS. 1997. PMID: 9147163 Review. No abstract available.
• Cytosine arabinoside in experimental combination therapy.

  Edelstein M, Valeriote F. Edelstein M, et al. Semin Oncol. 1985 Jun;12(2 Suppl 3):75-83. Semin Oncol. 1985. PMID: 3892705 Review. No abstract available.